Article

Continuous Manufacturing in Solid-Dosage Drug Production, an Interview with Doug Hausner, C-SOPS

An interview with Doug Hausner, C-SOPS, about continuous manufacturing

Continuous manufacturing offers the potential for improved quality, higher production efficiency, and smaller, more flexible equipment. Doug Hausner, Associate Director for the Engineering Research Center for Structured Organic Particulate Systems (C-SOPS) based at Rutgers University in New Jersey, USA, speaks with Pharmaceutical Technology about the current and future use of continuous processes in solid-dosage drug production.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
 Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Drug Digest: Patient Preference Drives Solid Dosage Trends
© 2025 MJH Life Sciences

All rights reserved.